Literature DB >> 8568232

Interaction of IL-15 with the shared IL-2 receptor beta and gamma c subunits. The IL-15/beta/gamma c receptor-ligand complex is less stable than the IL-2/beta/gamma c receptor-ligand complex.

J L de Jong1, N L Farner, M B Widmer, J G Giri, P M Sondel.   

Abstract

This study was designed to compare the interactions of IL-2 and IL-15 with the IL-2R beta and IL-2R gamma c subunits, as differences in receptor interactions between IL-2 and IL-15 might contribute to the functional differences between these two cytokines. The results suggest the existence of a human IL-15R alpha subunit, although physical evidence of this molecule was not obtained. Proliferation of anti-CD3 (OKT3)-stimulated human PBL was compared for responsiveness to IL-2, IL-15, and F42K, and IL-2 mutant that does not bind the IL-2R alpha chain. F42K was more potent than IL-15 in activating a dose-dependent response. This fact, along with Scatchard binding analyses of IL-15 on OKT3 blasts and YT cells revealing both high and intermediate affinity receptors, supports the existence of IL-15R alpha on these cells. Additional characterization of the IL-15R utilized covalent cross-linking to affinity label IL-2R and IL-15R on YT cells and OKT3 blasts. Consistent with previously reported functional data, IL-2R alpha was not co-precipitated from the [125I]IL-15 receptor-ligand complex, demonstrating that IL-15 does not interact physically with the IL-2R alpha subunit. While IL-2R alpha did co-precipitate with IL-2R beta and IL-2R gamma c in the presence of IL-2, IL-15R alpha did not co-precipitate with the IL-2R beta/gamma c complex. Finally, YT cells equilibrated with IL-2 and then precipitated through IL-2R beta showed that IL-2R beta and IL-2R gamma c co-precipitate in a 1:1 ratio, while only IL-2R beta was found in the immunoprecipitates of YT cells equilibrated with IL-15. This indicates that IL-15 creates a less stable bridge between the IL-2R beta and IL-2R gamma c chains than does IL-2 on YT cells. This result was identical for both surface-iodinated YT cells and immunoprecipitates that were probed for IL-2R beta and IL-2R gamma c on Western blots.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8568232

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

1.  Combined IL-15/IL-15Ralpha immunotherapy maximizes IL-15 activity in vivo.

Authors:  Thomas A Stoklasek; Kimberly S Schluns; Leo Lefrançois
Journal:  J Immunol       Date:  2006-11-01       Impact factor: 5.422

2.  Targeting the IL-15 receptor with an antagonist IL-15 mutant/Fc gamma2a protein blocks delayed-type hypersensitivity.

Authors:  Y S Kim; W Maslinski; X X Zheng; A C Stevens; X C Li; G H Tesch; V R Kelley; T B Strom
Journal:  J Immunol       Date:  1998-06-15       Impact factor: 5.422

Review 3.  A primer on cytokines: sources, receptors, effects, and inducers.

Authors:  J H Curfs; J F Meis; J A Hoogkamp-Korstanje
Journal:  Clin Microbiol Rev       Date:  1997-10       Impact factor: 26.132

4.  CD4 effector T cell differentiation is controlled by IL-15 that is expressed and presented in trans.

Authors:  Adam T Waickman; Davinna L Ligons; SuJin Hwang; Joo-Young Park; Vanja Lazarevic; Noriko Sato; Changwan Hong; Jung-Hyun Park
Journal:  Cytokine       Date:  2017-08-12       Impact factor: 3.861

5.  NFĸB is an unexpected major mediator of interleukin-15 signaling in cerebral endothelia.

Authors:  Kirsten P Stone; Abba J Kastin; Weihong Pan
Journal:  Cell Physiol Biochem       Date:  2011-08-16

6.  Rapid endocytosis of interleukin-15 by cerebral endothelia.

Authors:  Kirsten P Stone; Abba J Kastin; Hung Hsuchou; Chuanhui Yu; Weihong Pan
Journal:  J Neurochem       Date:  2011-01-19       Impact factor: 5.372

7.  IL-15: a novel prosurvival signaling pathway in cardiomyocytes.

Authors:  Yerem Yeghiazarians; Norman Honbo; Isabella Imhof; Brandon Woods; Vanessa Aguilera; Jianqin Ye; Andrew J Boyle; Joel S Karliner
Journal:  J Cardiovasc Pharmacol       Date:  2014-05       Impact factor: 3.105

8.  Qualitatively different T cell phenotypic responses to IL-2 versus IL-15 are unified by identical dependences on receptor signal strength and duration.

Authors:  Abhinav Arneja; Hannah Johnson; Laura Gabrovsek; Douglas A Lauffenburger; Forest M White
Journal:  J Immunol       Date:  2013-12-02       Impact factor: 5.422

9.  Cerebral microvascular IL15 is a novel mediator of TNF action.

Authors:  Weihong Pan; Chuanhui Yu; Hung Hsuchou; Reas S Khan; Abba J Kastin
Journal:  J Neurochem       Date:  2009-08-31       Impact factor: 5.372

10.  The influence of IL-2 family cytokines on activation and function of naturally occurring regulatory T cells.

Authors:  Thomas Y Wuest; Jami Willette-Brown; Scott K Durum; Arthur A Hurwitz
Journal:  J Leukoc Biol       Date:  2008-07-23       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.